Family history of cancer and risk of second malignancies in young cancer patients in Trieste, Italy

International Journal of Cancer

Volumn 115, Issue 5, 2005, Pages 814-821

  Brunetti, Davide ^a   Tamaro, Paolo ^b   Fanin, Renato ^c   Cavallieri, Furio ^a   Stanta, Giorgio ^a,d  

^a Maggiore Hospital   (Italy)

^b INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^c UNIVERSITY OF UDINE   (Italy)

^d MAGGIORE HOSPITAL   (Italy)

Author keywords

Adolescents; Children; Family risk index; Second primary cancer; Young adults

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BONE TUMOR; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RISK; CECUM CARCINOMA; CHI SQUARE TEST; CHILD; CHILDHOOD CANCER; COHORT ANALYSIS; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; FOLLOW UP; GERM CELL TUMOR; HUMAN; INFANT; ITALY; KIDNEY TUMOR; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; MELANOMA; NERVOUS SYSTEM TUMOR; NEUROFIBROMATOSIS; NONHODGKIN LYMPHOMA; PEDIGREE; PRIORITY JOURNAL; RELATIVE; RETICULOENDOTHELIAL NEOPLASM; RETINOBLASTOMA; SECOND CANCER; SKIN CANCER; SOFT TISSUE SARCOMA; THYROID CARCINOMA; TURCOT SYNDROME; ULCERATIVE COLITIS; XERODERMA PIGMENTOSUM;

ADULT; AGE OF ONSET; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; INFANT, NEWBORN; ITALY; MALE; MEDICAL HISTORY TAKING; NEOPLASMS, SECOND PRIMARY; PEDIGREE; RISK FACTORS;

EID: 20144372539     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20932     Document Type: Article

References (39)

1. Hawkins MM, Draper GJ, Kingston JE. Incidence of second primary tumours among childhood cancer survivors. Br J Cancer 1987;56: 339-47.
2. Olsen JH, Garwicz S, Hertz H, Jonmundsson G, Langmark F, Lanning M, Lie SO, Moe PJ, Møller T, Sankila R, Tulinius H, Nordic Society of Paediatric Haematology and Oncology, Association of the Nordic Cancer Registries. Second malignant neoplasms after cancer in childhood or adolescence. Br Med J 1993;307:1030-6.
3. Magnani C, Terracini B, Cordero di Montezemolo L, Gallone G. Luzzatto L, Mosso ML, Pastore G, Rosso P. Incidence of second primary malignancies after a malignant tumor in childhood: a population-based survey in Piedmont (Italy). Int J Cancer 1996;67:6-10.
4. Westermeier T, Kaatsch P, Schoetzau A, Michaelis J. Multiple primary neoplasms in childhood: data from the German Children's Cancer Registry. Eur J Cancer 1998;34:687-93.
5. Jazbec J, Ećimović P, Jereb B. Second neoplasms after treatment of childhood cancer in Slovenia. Pediatr Blood Cancer 2004;42:574-81.
6. Schottenfeld D. Multiple primary cancers. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer epidemiology and prevention, 2nd ed. New York: Oxford University Press, 1996. 1370-87.
7. Kingston JE, Hawkins MM, Draper GJ, Marsden HB, Kinnier Wilson LM. Patterns of multiple primary tumours in patients treated for cancer during childhood. Br J Cancer 1987;56:331-8.
8. Meadows AT, Baum E, Fossati-Bellani F, Green D, Jenkin RDT, Marsden B, Nesbit M, Newton W, Oberlin O, Sallan SG, Siegel S, Strong LC, et al. Second malignant neoplasms in children: an update from the Late Effects Study Group. J Clin Oncol 1985;3:532-8.
9. Moll AC, Imhof SM, Bouter LM, Kuik DJ, Den Otter W, Bezemer PD, Koten JW, Tan KEWP. Second primary tumors in patients with hereditary retinoblastoma: a register-based follow-up study, 1945-1994. Int J Cancer 1996;67:515-9.
10. Garwicz S, Anderson H, Olsen JH, Døllner H, Hertz H, Jonmundsson G, Langmark F, Lanning M, Möller T, Sankila R. Tulinius H, Nordic Society for Pediatric Hematology and Oncology, Association of the Nordic Cancer Registries. Second malignant neoplasms after cancer in childhood and adolescence: a population-based case-control study in the 5 Nordic countries. Int J Cancer 2000;88:672-8.
11. Little MP, de Vathaire F, Shamsaldin A, Oberlin O, Campbell S, Grimaud E, Chavaudra J, Haylock RGE, Muirhead CR. Risks of brain tumour following treatment for cancer in childhood: modification by genetic factors, radiotherapy and chemotherapy. Int J Cancer 1998;78:269-75.
12. Hisada M, Garber JE, Fung CY, Fraumeni JF Jr, Li FP. Multiple primary cancers in families with Li-Fraumeni syndrome. J Natl Cancer Inst 1998;90:606-11.
13. de Vathaire F, François P, Hill C, Schweisguth O, Rodary C, Sarrazin D, Oberlin O, Beurtheret C, Dutreix A, Flamant R. Role of radiotherapy and chemotherapy in the risk of second malignant neoplasms after cancer in childhood. Br J Cancer 1989;59:792-6.
14. Tucker MA, Morris Jones PH, Boice JD Jr, Robison LL, Stone BJ, Stovall M, Jenkin RDT, Lubin JH, Baum ES, Siegel SE, Meadows AT, Hoover RN, et al. Therapeutic radiation at a young age is linked to secondary thyroid cancer. Cancer Res 1991;51:2885-8.
15. Hawkins MM, Kinnier Wilson LM, Stovall MA, Marsden HB, Potok MHN, Kingston JE, Chessells JM. Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukaemia after childhood cancer. Br Med J 1992;304:951-8.
16. Green DM, Zevon MA, Reese PA, Lowrie GS, Gaeta JF, Pearce JI, Michalek AM, Stephens EA. Second malignant tumors following treatment during childhood and adolescence for cancer. Med Pediatr Oncol 1994;22:1-10.
17. Hawkins MM, Kinnier Wilson LM, Burton HS, Potok MHN, Winter DL, Marsden HB, Stovall MA. Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer. J Natl Cancer Inst 1996; 88:270-8.
18. de Vathaire F, Hawkins M, Campbell S, Oberlin O, Raquin M-A, Schlienger J-Y, Shamsaldin A, Diallo I, Bell J, Grimaud E, Hardiman C, Lagrange J-L, et al. Second malignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatment. Br J Cancer 1999;79:1884-93.
19. Neglia JP, Friedman DL, Yasui Y, Mertens AC, Hammond S, Stovall M, Donaldson SS, Meadows AT, Robison LL. Second malignant neoplasms in five-year survivors of childhood cancer: Childhood Cancer Survivor Study. J Natl Cancer Inst 2001;93:618-29.
20. Gold DG, Neglia JP, Dusenbery KE. Second neoplasms after mega-voltage radiation for pediatric tumors. Cancer 2003;97:2588-96.
21. Klein G, Michaelis J, Spix C, Wibbing R, Eggers G, Ritter J, Kaatsch P. Second malignant neoplasms after treatment of childhood cancer. Eur J Cancer 2003;39:808-17.
22. Rubino C, Adjadi E, Guérin S, Guibout C, Shamsaldin A, Dondon M-G, Valteau-Couanet D, Hartmann O, Hawkins M, de Vathaire F. Long-term risk of second malignant neoplasms after neuroblastoma in childhood: role of treatment. Int J Cancer 2003;107:791-6.
23. Menu-Branthomme A, Rubino C, Shamsaldin A, Hawkins MM, Grimaud E, Dondon M-G, Hardiman C, Vassal G, Campbell S, Panis X, Daly-Schveitzer N, Lagrange J-L, et al. Radiation dose, chemotherapy and risk of soft tissue sarcoma after solid tumours during childhood. Int J Cancer 2004;110:87-93.
24. Kony SJ, de Vathaire F, Chompret A, Shamsaldim A, Grimaud E, Raquin M-A, Oberlin O, Brugières L, Feunteun J, Eschwège F, Chavaudra J, Lemerle J, et al. Radiation and genetic factors in the risk of second malignant neoplasms after a first cancer in childhood. Lancet 1997;350:91-5.
25. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J, eds. Cancer incidence in five continents, vol. 7. Lyon: IARC, 1997.562-5.
26. Kramárová E, Stiller CA. The International Classification of Childhood Cancer. Int J Cancer 1996;68:759-65.
27. Brunetti D, Tamaro P, Stanta G. Malignancies among adolescents and young adults in the province of Trieste, Italy, 1972-1993: similarities and dissimilarities to childhood cancer. Epidemiol Prev 2002;26: 130-9.
28. Parkin DM, Chen VW, Ferlay J, Galceran J, Storm HH, Whelan SL. Comparability and quality control in cancer registration. Lyon: IARC, 1994. 1-6, 51-2.
29. Mulvihill JJ. Catalog of human cancer genes: McKusick's Mendelian inheritance in man for clinical and research oncologists (Onco-MIM). Baltimore, MD: Johns Hopkins University Press, 1999.
30. Correa P. Morphology and natural history of cancer precursors. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer epidemiology and prevention, 2nd ed. New York: Oxford University Press, 1996. 45-64.
31. Coleman MP, Hermon C, Douglas A. PERSON-YEARS (PYRS): a Fortran program for cohort study analysis. Lyon: IARC, 1989.
32. Breslow NE, Day NE. Statistical methods in cancer research, vol. 2, the design and analysis of cohort studies. Lyon: IARC, 1987. 65-76. 93-8, 120-53.
33. Estève J, Benhamou E, Raymond L. Statistical methods in cancer research, vol. 4, descriptive epidemiology. Lyon: IARC, 1994. 64-5.
34. Schwanz AG, Boehnke M, Moll PP. Family risk index as a measure of familial heterogeneity of cancer risk: a population-based study in metropolitan Detroit. Am J Epidemiol 1988;128:524-35.
35. Khoury MJ, Beaty TH, Cohen BH. Fundamentals of genetic epidemiology. New York: Oxford University Press, 1993. 185-8.
36. Brunetti D, Tamaro P, Cavallieri F, Stanta G. Malignant tumors in first-degree relatives of cancer patients aged 0-25 years (province of Trieste, Italy). Int J Cancer 2003;106:252-9.
37. Giannelli F, Avery J, Polani PE, Terrell C, Giammusso V. Xeroderma pigmentosum and medulloblastoma: chromosomal damage to lymphocytes during radiotherapy. Radiat Res 1981;88:194-208.
38. Ponder BAJ. Cancer genetics. Nature 2001;411:336-41.
39. Narod SA, Stiller C, Lenoir GM. An estimate of the heritable fraction of childhood cancer. Br J Cancer 1991;63:993-9.